Correlation Between Pasithea Therapeutics and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and ATyr Pharma, you can compare the effects of market volatilities on Pasithea Therapeutics and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and ATyr Pharma.
Diversification Opportunities for Pasithea Therapeutics and ATyr Pharma
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Pasithea and ATyr is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and ATyr Pharma go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and ATyr Pharma
If you would invest (100.00) in ATyr Pharma on August 28, 2024 and sell it today you would earn a total of 100.00 from holding ATyr Pharma or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. ATyr Pharma
Performance |
| Timeline |
| Pasithea Therapeutics |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pasithea Therapeutics and ATyr Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and ATyr Pharma
The main advantage of trading using opposite Pasithea Therapeutics and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |